USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boehringer Ingelheim Pharma Gmbh & Co. KG

USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

The verdict

According to USPTO PatentsView, Boehringer ranks #24,011 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 9 technology areas.

#24,011
of 50,000 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
17.1
avg claims per patent
-90%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24011 · Foreign Corporation #24,011 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,011/50,000
  • PHOTO-FINISH BLUE TOMATO
  • CPC-NARROW A61M · 9 areas
  • INNOV-THIN 36.1/100
  • CLAIMS-RICH 17.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -90% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: BLUE Tomato, Llc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Boehringer

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Boehringer's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Boehringer's grants concentrate

Boehringer Ingelheim Pharma Gmbh & Co. KG is a focused PatentsView assignee: 9 CPC subclasses with 45.5% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Boehringer sits between BLUE Tomato, Llc and Bormioli Pharma S.p.a..

Boehringer's three-year grant acceleration

Boehringer Ingelheim Pharma Gmbh & Co. KG shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Boehringer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Boehringer holds 11 patents at rank #23,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Boehringer

By rank, the assignees closest to #23,974 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Boehringer's primary technology class.

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Boehringer Ingelheim Pharma Gmbh & Co. KG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 54.5%
2016 2 18.2%
2017 1 9.1%
2018 1 9.1%
2023 1 9.1%

Where it ranks

Overall rank by patents

#24,011

of 50,000 tracked assignees

Innovation Score

36.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.